Compare · ICCM vs MDLN
ICCM vs MDLN
Side-by-side comparison of IceCure Medical Ltd. (ICCM) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICCM and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 13492.3x ICCM ($3.6M).
- Over the past year, ICCM is down 95.7% and MDLN is down 11.8% - MDLN leads by 83.9 points.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 5 for ICCM).
- MDLN has more recent analyst coverage (25 ratings vs 2 for ICCM).
PerformanceICCM-94.84%MDLN-11.77%
2025-12-17+0.00%2026-10-16
- Company
- IceCure Medical Ltd.
- Medline Inc.
- Price
- $1.05+1.93%
- $35.95-1.74%
- Market cap
- $3.6M
- $48.08B
- 1M return
- -47.12%
- +11.97%
- 1Y return
- -95.69%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 5
- 7
- Recent ratings
- 2
- 25
ICCM
IceCure Medical Ltd.
IceCure Medical Ltd develops and markets minimally invasive cryoablation therapies for women's health and oncology markets. It offers ProSense system, a cryoablation solution for breast tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.
Latest ICCM
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
- SEC Form 6-K filed by IceCure Medical Ltd.
- SEC Form 6-K filed by IceCure Medical Ltd.
- SEC Form 6-K filed by IceCure Medical Ltd.
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Medical Receives Regulatory Approval to Market ProSense® in China
- SEC Form 6-K filed by IceCure Medical Ltd.
- IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
- West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M